Biotechnica DWC
Biotechnica DWC is a privately held Algerian pharmaceutical services company, founded in 1996 and headquartered in Ben 'aknoûn, providing an integrated spectrum of pharmaceutical services with a headcount of 11-50 employees.
- Company typePrivate
- Founded1996
- HeadquartersBen 'aknoûn, Algeria
- Headcount11–50
- GTM typeB2B
- OfferingServices
Biotechnica DWC firmographics
Firmographics- Name
- Biotechnica DWC
- Website
- https://biotechnica-pharma.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Biotechnica DWC is a privately held Algerian pharmaceutical services company, founded in 1996 and headquartered in Ben 'aknoûn, providing an integrated spectrum of pharmaceutical services with a headcount of 11-50 employees.
- Ownership category
- akta.pro rank
Biotechnica DWC industry classification
Industry- Product category
- Pharmaceutical Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)
Keywords
Where Biotechnica DWC is headquartered
LocationHeadquarters
- HQ city
- Ben 'aknoûn
- HQ country
- Algeria
- HQ region
- Africa
Markets served
Biotechnica DWC business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Biotechnica DWC product offering
Product offeringCore offering
Biotechnica DWC is an integrated pharmaceutical services company providing the entire spectrum of pharmaceutical services. Based on the available market context, the company operates within the rapid diagnostic solutions space, including C-Reactive Protein (CRP) testing for point-of-care diagnosis of inflammatory and infectious conditions, serving healthcare providers and diagnostic facilities.
Product overview
Based on the available source data, no specific product or service information for Biotechnica DWC could be extracted. The news source discusses the broader C-Reactive Protein (CRP) rapid test market rather than the company's individual product portfolio. The company website was inaccessible due to a verification/loading page.
Differentiator
Problem solved
Functional benefit
Products and services
- Integrated pharmaceutical services Full-spectrum pharmaceutical services offering, inclusive of rapid diagnostic solutions such as C-Reactive Protein (CRP) rapid tests, provided to healthcare providers and diagnostic facilities for point-of-care diagnosis of inflammatory and infectious diseases.
Companies that use Biotechnica DWC
Customer profileSegments1 record
Ideal customer profiles1 record
Biotechnica DWC technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Biotechnica DWC partnerships and signals
Strategic signalScale indicators1 record
Expansion highlights1 record
Biotechnica DWC competitors and assessment
Company assessmentBroad incumbents
- Hikma Pharmaceuticals: A major MENA-headquartered (Jordan) pharmaceutical manufacturer and services provider with a broad product and service portfolio. Comparable to Biotechnica DWC as an established MENA pharma player, though operating at far greater scale and with international regulatory reach.
- Catalent: A global pharmaceutical services company offering development, analytical, and manufacturing services across dosage forms. Comparable to Biotechnica DWC as a peer in the pharmaceutical services value chain, though at vastly different scale and global reach.
Regional players
- Julphar (Gulf Pharmaceutical Industries): A UAE-based pharmaceutical manufacturer serving MENA markets with a broad generics and healthcare portfolio. Comparable to Biotechnica DWC as a regional pharma services and manufacturing peer, though with substantially larger capacity and geographic spread.
- EIPICO (Egyptian International Pharmaceutical Industries Company): One of Egypt's largest pharmaceutical manufacturers with a broad product portfolio across MENA. Comparable to Biotechnica DWC as a regional pharmaceutical player serving North African healthcare providers, though with a much more developed commercial and export footprint.
- SPIMACO Addwaeih: A Saudi Arabia-based pharmaceutical manufacturer with MENA-wide distribution. Comparable to Biotechnica DWC as a regional pharma services counterpart serving public and private healthcare buyers in the MENA region.
- Aspen Pharmacare: Africa's largest pharmaceutical manufacturer, headquartered in South Africa, with growing presence across the continent. Comparable to Biotechnica DWC as an Africa-based pharmaceutical services peer serving emerging-market healthcare needs.
- Pharco Pharmaceuticals: One of the largest Egyptian pharmaceutical companies, with a broad generics and biosimilars portfolio serving MENA. Comparable to Biotechnica DWC as a North African pharmaceutical services and manufacturing counterpart competing for the same regional customer base.
Emerging players
- Cipla: An India-headquartered global pharmaceutical company with a strong emerging-markets franchise, including Africa. Comparable to Biotechnica DWC in that both serve demand for affordable pharmaceutical and diagnostic services in developing markets, though Cipla operates at vastly greater scale.
Direct peers
- Charles River Laboratories: A global CRO offering laboratory services, analytical development, and QC testing for pharma and biotech clients. Comparable to Biotechnica DWC as a peer in the contract laboratory and analytical services space, though operating globally with full GLP/GMP accreditations.
- Quotient Sciences: A pharmaceutical services company offering drug development, manufacturing, and analytical services across small molecules. Comparable to Biotechnica DWC as a peer offering integrated pharmaceutical services across the development lifecycle.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat2 records
Key risks6 records
Key highlights4 records
Customer concentration
Biotechnica DWC social profiles
Digital presenceBiotechnica DWC financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biotechnica DWC leadership team
Management profileNumber of profiles
Biotechnica DWC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biotechnica DWC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biotechnica DWC
What does Biotechnica DWC do?
Biotechnica DWC is an integrated pharmaceutical services company providing the entire spectrum of pharmaceutical services. Based on the available market context, the company operates within the rapid diagnostic solutions space, including C-Reactive Protein (CRP) testing for point-of-care diagnosis of inflammatory and infectious conditions, serving healthcare providers and diagnostic facilities.
Is Biotechnica DWC a public or private company?
Biotechnica DWC is a private company. It is classified as unknown and is currently operating.
When was Biotechnica DWC founded?
Biotechnica DWC was founded in 1996. It employs 11 to 50 people.
Where is Biotechnica DWC based?
Biotechnica DWC is headquartered in Ben 'aknoûn, Algeria, in the Africa region.
Who are Biotechnica DWC's main competitors?
Broad incumbents on record are Hikma Pharmaceuticals and Catalent. Regional players are Julphar (Gulf Pharmaceutical Industries), EIPICO (Egyptian International Pharmaceutical Industries Company), SPIMACO Addwaeih, Aspen Pharmacare and Pharco Pharmaceuticals. Cipla is listed as an emerging player. Direct peers are Charles River Laboratories and Quotient Sciences.
Does Biotechnica DWC have an API?
No public API is recorded for Biotechnica DWC.
What industry is Biotechnica DWC in?
Biotechnica DWC's product category is Pharmaceutical Services. Its primary akta.pro industry code is HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 621511 and its SIC code is 8071.